![Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? [Tz8JKLqMk37]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/07/ced-pexels-5021600.jpg?resize=150%2C150&ssl=1 "Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? 14")
#67
Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
This WHO update on cannabis risks signifies important implications for clinicians and their patients. The confirmation of a link between cannabis use and an increased risk of psychotic episodes, particularly in individuals with a predisposition to mental health issues, underscores the need for healthcare professionals to consider this factor when counseling patients about cannabis use. This update also highlights the importance of ongoing research and evidence-based approaches in guiding clinical practice related to cannabis.
The World Health Organization (WHO) has updated its assessment on cannabis risks, citing new evidence linking its use to an elevated risk of psychotic episodes, particularly in individuals with a predisposition to mental health disorders. This update underscores the importance for clinicians to consider potential psychiatric complications when assessing and managing patients using cannabis.
“As a seasoned family physician specializing in cannabis medicine, I find the World Health Organization’s updated assessment on cannabis risks particularly noteworthy. The new research underscores a connection between cannabis use and an elevated risk of psychotic episodes, especially among individuals with predisposed vulnerabilities. However, it is crucial to emphasize that this finding should be interpreted within the context of ongoing research and individual patient factors.”
🔬 A recent update by the World Health Organization (WHO) highlights a strengthened association between cannabis use and an elevated risk of psychotic episodes, particularly in individuals with a predisposition to mental health disorders. This underscores the complexity of cannabis’s impact on patient health, as factors such as age at first use, frequency, potency, and specific cannabinoid profiles may significantly influence outcomes. In clinical practice, healthcare providers should remain vigilant for signs of psychosis in patients who use cannabis, especially those with a personal or family history of mental illness. This awareness can facilitate early intervention and potentially mitigate the negative consequences associated with cannabis use.
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it:
